The sterile injectables CDMO market offers opportunities in drug development of biologics, biosimilars, and personalized ...

The generic sterile injectables market accounted for $ 68.7 billion in 2019 and is estimated to be $196.2 billion by 2029 and is anticipated to register a CAGR of 11.2%, per a report from Prophecy ...

Is Demand for Sterile Injectable Products Driven by Increased Chronic Disease? Chronic disease is on the rise globally with such diseases as cancer, diabetes, and cardiovascular disease; therefore ...

Sharp is honing its edge in the growing sterile injectables market by expanding its production capacity for secondary packaging at its facility in Macungie, Pennsylvania. Although Sharp didn’t ...

Over the past few years, drug shortages have become an ever-present challenge for hospital pharmacies, with shortages at their highest in over a decade1 and the majority of those, 53 percent, were for ...

With an eye toward averting drug shortages and sterility question marks, the US Food and Drug Administration (FDA) is modernizing its inspections program with a new way of assessing, recording and ...

BRIDGEWATER, N.J., May 02, 2022 (GLOBE NEWSWIRE) -- Nevakar Injectables Inc. (“Nevakar”), a wholly owned subsidiary of Nevakar, Inc., is a biopharmaceutical company developing multiple sterile ...

Jubilant Pharmova's FY26 revenue grew 14% YoY to Rs 8,280 crore, driven by its CDMO, Generics, and Allergy segments. EBITDA ...

After years of manufacturing woes, Pfizer appeared to turn a corner earlier this year for its growing sterile injectables portfolio. But even with signs trending upward, Pfizer is preparing to exit an ...

BRIDGEWATER, N.J., April 28, 2022 (GLOBE NEWSWIRE) -- Nevakar Injectables Inc. (“Nevakar”), a wholly owned subsidiary of Nevakar, Inc., is a biopharmaceutical company developing multiple sterile ...

Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that the company will participate in ...